Japan, China and South Korea Meet Towards Clinical Data Mutual Acceptance
This article was originally published in PharmAsia News
Executive Summary
The third round of meetings among pharmaceutical review regulators from Japan, China and South Korea met in Seoul to discuss clinical data acceptance